Success Metrics

Clinical Success Rate
91.7%

Based on 33 completed trials

Completion Rate
92%(33/36)
Active Trials
10(16%)
Results Posted
24%(8 trials)
Terminated
3(5%)

Phase Distribution

Ph phase_3
12
20%
Ph early_phase_1
2
3%
Ph not_applicable
5
8%
Ph phase_2
12
20%
Ph phase_1
11
18%
Ph phase_4
19
31%

Phase Distribution

13

Early Stage

12

Mid Stage

31

Late Stage

Phase Distribution61 total trials
Early Phase 1First-in-human
2(3.3%)
Phase 1Safety & dosage
11(18.0%)
Phase 2Efficacy & side effects
12(19.7%)
Phase 3Large-scale testing
12(19.7%)
Phase 4Post-market surveillance
19(31.1%)
N/ANon-phased studies
5(8.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

84.6%

33 of 39 finished

Non-Completion Rate

15.4%

6 ended early

Currently Active

10

trials recruiting

Total Trials

61

all time

Status Distribution
Active(13)
Completed(33)
Terminated(6)
Other(9)

Detailed Status

Completed33
unknown9
Recruiting6
Active, not recruiting4
Terminated3
Withdrawn3

Development Timeline

Analytics

Development Status

Total Trials
61
Active
10
Success Rate
91.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (3.3%)
Phase 111 (18.0%)
Phase 212 (19.7%)
Phase 312 (19.7%)
Phase 419 (31.1%)
N/A5 (8.2%)

Trials by Status

terminated35%
recruiting610%
withdrawn35%
active_not_recruiting47%
completed3354%
not_yet_recruiting35%
unknown915%

Recent Activity

Clinical Trials (61)

Showing 20 of 61 trialsScroll for more
NCT07221162Phase 1

A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes

Recruiting
NCT06745921Phase 1

Safety and Immunogenicity of an Inactivated West Nile Virus Vaccine in Healthy Adults

Active Not Recruiting
NCT06735209Phase 1

First-in-Human PfSPZ-LARC2 Vaccination/CHMI

Active Not Recruiting
NCT05945485Phase 1

A Study to Evaluate the Safety and Immunogenicity of Two Doses of DCVC H1 HA mRNA-LNP in Healthy Adults

Active Not Recruiting
NCT07525934Not Applicable

Intravenous Dexamethasone as an Adjuvant to Dexmedetomidine After Superior Trunk Block for Arthroscopic Shoulder Surgery

Not Yet Recruiting
NCT03834129Phase 3

Dexmedetomidine Intra Venous Arthroplasty

Completed
NCT03734159Phase 4

The Benefit of Local Anesthesia at the Sternum in Patients With Coronary Surgery

Completed
NCT02029898Phase 1

Remifentanil for General Anesthesia in the Context of Immaturity

Completed
NCT07224711Phase 4

The Impact of Perioperative Lidocaine Infusions on Enhanced Recovery After Non-Cardiac Surgery

Not Yet Recruiting
NCT07254429Phase 2

COMPASS - COpenhagen MenoPAuSe Study

Recruiting
NCT07167693Phase 1

Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes

Recruiting
NCT07019883Phase 1

A Study to Evaluate the Safety and Immunogenicity of Two Doses of a Novel H5 Central Antigen mRNA-LNP in Healthy Adults

Active Not Recruiting
NCT06845358Phase 1

Safety and Challenge Study of BCG TICE(R) Vaccination to Test Tuberculosis Immunity in Heathy Humans

Withdrawn
NCT05755620Phase 1

A Study to Evaluate the Safety and Immunogenicity of a Single Dose of H1ssF-3928 mRNA-LNP in Healthy Adults

Completed
NCT05289037Phase 2

COVID-19 Variant Immunologic Landscape Trial (COVAIL Trial)

Completed
NCT03227263Phase 3

BABH Study: Efficacy and Safety of Bevacizumab on Severe Bleedings Associated With Hemorrhagic Hereditary Telangiectasia (HHT).

Completed
NCT04588311Phase 3

ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients

Recruiting
NCT04776317Phase 1

Chimpanzee Adenovirus and Self-Amplifying mRNA Prime-Boost Prophylactic Vaccines Against SARS-CoV-2 in Healthy Adults

Completed
NCT06961383Phase 2

Study of NG01 Cell Therapy in Secondary Progressive Multiple Sclerosis

Not Yet Recruiting
NCT03714360Phase 4

The Effect of Tranexamic Acid. A Randomised Study of Patients Undergoing Elective Lumbar Spine Surgery.

Completed

Drug Details

Intervention Type
OTHER
Total Trials
61